Evaluation of overexpression of HER2/neu in primary uterine, ovarian, and peritoneal papillary serous carcinoma

被引：0
|
作者：
Hatami, M.
Goldberg, G.
Whitney, K.
机构：
[1] AECOM, New York, NY USA
[2] Shahid Beheshti Univ, Tehran, Iran
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e15512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15512
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Her-2/neu overexpression and amplification in uterine papillary serous carcinoma
    Slomovitz, BM
    Broaddus, RR
    Burke, TW
    Sneige, N
    Soliman, PT
    Wu, WG
    Sun, CC
    Munsell, MF
    Gershenson, DM
    Lu, KH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 3126 - 3132
  • [2] HER2/neu overexpression: has the Achilles' heel of uterine serous papillary carcinoma been exposed?
    Santin, AD
    GYNECOLOGIC ONCOLOGY, 2003, 88 (03) : 263 - 265
  • [3] Her-2/neu overexpression and amplification in uterine papillary serous carcinoma (UPSC).
    Slomovitz, BM
    Broaddus, RR
    Burke, TW
    Sneige, N
    Gershenson, DM
    Lu, KH
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 410A - 410A
  • [4] Overexpression of HER-2/neu in uterine serous papillary cancer
    Santin, AD
    Bellone, S
    Gokden, M
    Palmieri, M
    Dunn, D
    Agha, J
    Roman, JJ
    Hutchins, L
    Pecorelli, S
    O'Brien, T
    Cannon, MJ
    Parham, GP
    CLINICAL CANCER RESEARCH, 2002, 8 (05) : 1271 - 1279
  • [5] HER2/neu Overexpression and Recurrence Risk in Early Stage Uterine Serous Carcinoma
    Blakaj, A.
    Jairam, V.
    Buza, N.
    Schwartz, P.
    Santin, A.
    Damast, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S218 - S219
  • [6] HER2 Immunohistochemistry Significantly Overestimates HER2 Amplification in Uterine Papillary Serous Carcinoma
    Mentrikoski, M. J.
    Stowman, A.
    Stoler, M. H.
    MODERN PATHOLOGY, 2014, 27 : 296A - 296A
  • [7] Clinical significance of Her-2/neu overexpression in uterine serous carcinoma
    Díaz-Montes, TP
    Ji, HX
    Sehdev, AES
    Zahurak, ML
    Kurman, RJ
    Armstrong, DK
    Bristow, RE
    GYNECOLOGIC ONCOLOGY, 2006, 100 (01) : 139 - 144
  • [8] HER2 Immunohistochemistry Significantly Overestimates HER2 Amplification in Uterine Papillary Serous Carcinoma
    Mentrikoski, M. J.
    Stowman, A.
    Stoler, M. H.
    LABORATORY INVESTIGATION, 2014, 94 : 296A - 296A
  • [9] Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization
    Santin, AD
    Bellone, S
    Van Stedum, S
    Bushen, W
    De Las Casas, LE
    Korourian, S
    Tian, E
    Roman, JJ
    Burnett, A
    Pecorelli, S
    GYNECOLOGIC ONCOLOGY, 2005, 98 (01) : 24 - 30
  • [10] HER-2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications
    Villella, J. A.
    Cohen, S.
    Smith, D. H.
    Hibshoosh, H.
    Hershman, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (05) : 1897 - 1902
12345